New hope for tough depression? drug trial targets Non-Responders
NCT ID NCT07284667
First seen Jan 04, 2026 · Last updated Jun 17, 2026 · Updated 25 times
Summary
This study tests a new medicine called ACP-211 in adults with major depression who haven't gotten better with standard antidepressants. About 153 people will receive either the drug or a placebo for 28 days. The main goal is to see if ACP-211 reduces depression symptoms more than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
CenExel Hassman Research Institute, LLC
ACTIVE_NOT_RECRUITINGMarlton, New Jersey, 08053, United States
-
Clinical Neuroscience Solutions, Inc.
RECRUITINGOrlando, Florida, 32801, United States
-
Dynamed Clinical Research LP d/b/a DM Clinical Research
ACTIVE_NOT_RECRUITINGHouston, Texas, 77081, United States
-
Family Psychiatry of The Woodlands
RECRUITINGThe Woodlands, Texas, 77381, United States
-
IPTB Clinical Research
RECRUITINGTampa, Florida, 33629, United States
-
Inland Psychiatric Medical Group
RECRUITINGChino, California, 91710, United States
-
Integrative Clinical Trials LLC
RECRUITINGBrooklyn, New York, 11229, United States
-
Kadima Neuropsychiatry Institute
RECRUITINGLa Jolla, California, 92037, United States
-
Magnolia Clinical Research, LLC
RECRUITINGCary, North Carolina, 27511, United States
-
Mountain View Clinical Research
RECRUITINGDenver, Colorado, 80209, United States
-
Neuro-Behavioral Clinical Research
RECRUITINGNorth Canton, Ohio, 44720, United States
-
Neuroscience Research Institute, Inc.
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Olympus Clinical Research, LLC
RECRUITINGKaty, Texas, 77450, United States
-
PNS Clinical Research LLC dba ATP Clinical Research
RECRUITINGOrange, California, 92866, United States
-
Redbird Research LLC
RECRUITINGLas Vegas, Nevada, 89134, United States
-
Sandhill Research, LLC/DBA Accel Research Sites
ACTIVE_NOT_RECRUITINGLargo, Florida, 33777, United States
-
St. Charles Psychiatric Associates, Inc. dba Midwest Research Group
RECRUITINGSaint Charles, Missouri, 63304, United States
-
The Medici Medical Research
RECRUITINGHollywood, Florida, 33021, United States
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
-
Vitalix Clinical, Inc.
RECRUITINGWorcester, Massachusetts, 01608, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.